TERT and neoplasm: The availability of tumor tissue has the advantage of allowing molecular analyses as well: in the last years, many approaches have been proposed, from microRNAs [6, 7] to gene hypermethylations [8, 9] and mutational profile, especially mutations in the promoter telomerase reverse transcriptase gene (TERT) [10, 11].